EVIDENCE FOR INHIBITION OF ACETYL-COENZYME A FORMATION FROM PYRUVATE IN DIABETIC RAT LIVER.
D000085:Acetates; D000818:Animals; D002245:Carbon Dioxide; D002247:Carbon Isotopes; D002784:Cholesterol; D003065:Coenzyme A; D003921:Diabetes Mellitus, Experimental; D005227:Fatty Acids / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D007328:Insulin; D049528:Insulin, Long-Acting; D007773:Lactates; D050356:Lipid Metabolism; D008099:Liver / Q000502:physiology*; D008112:Liver Glycogen; D010477:Perfusion; D010600:Pharmacology; D011479:Protamines; D011773:Pyruvates; D019289:Pyruvic Acid; D051381:Rats; D012106:Research; D014116:Toxicology; D014316:Tritium
D000085:Acetates; D002247:Carbon Isotopes; D005227:Fatty Acids; D007328:Insulin; D049528:Insulin, Long-Acting; D007773:Lactates; D008112:Liver Glycogen; D011479:Protamines; D011773:Pyruvates; C065206:protamine zinc; D014316:Tritium; D002245:Carbon Dioxide; D019289:Pyruvic Acid; D002784:Cholesterol; D005947:Glucose; D003065:Coenzyme A
ACETATES; ALLOXAN DIABETES; CARBON DIOXIDE; CARBON ISOTOPES; CHOLESTEROL; COENZYME A; EXPERIMENTAL LAB STUDY; FATTY ACID METABOLISM; GLUCOSE; GLUCOSE METABOLISM; INSULIN, PROTAMINE ZINC; LACTATES; LIPID METABOLISM; LIVER FUNCTION; LIVER GLYCOGEN; PERFUSION; PHARMACOLOGY; PYRUVATES; RATS; TOXICOLOGIC REPORT; TRITIUM